Mortality in ankylosing spondylitis: Results from a nationwide population-based study

Annals of the Rheumatic Diseases

Volumn 75, Issue 8, 2016, Pages 1466-1472

  Exarchou, Sofia ^a   Lie, Elisabeth ^b,c   Lindström, Ulf ^b   Askling, Johan ^d   Forsblad D'Elia, Helena ^e   Turesson, Carl ^a   Kristensen, Lars Erik ^a,f   Jacobsson, Lennart Th ^b  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c DIAKONHJEMMET HOSPITAL   (Norway)

^d KAROLINSKA INSTITUTE   (Sweden)

^e UMEÅ UNIVERSITY   (Sweden)

^f Parker Institute   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HIP REPLACEMENT; HUMAN; INFECTION; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MIDDLE AGED; MORTALITY RATE; PRIORITY JOURNAL; SEX RATIO; SOCIOECONOMICS; SURVIVAL RATE; SWEDE (PEOPLE); ADOLESCENT; ADVERSE EFFECTS; CAUSE OF DEATH; EPIDEMIOLOGY; KAPLAN MEIER METHOD; MORTALITY; REGISTER; RISK FACTOR; SPONDYLITIS, ANKYLOSING; SWEDEN; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; CAUSE OF DEATH; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; REGISTRIES; RISK FACTORS; SEX DISTRIBUTION; SOCIOECONOMIC FACTORS; SPONDYLITIS, ANKYLOSING; SWEDEN; YOUNG ADULT;

EID: 84940943217     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2015-207688     Document Type: Article

References (37)

1. Braun J, Sieper J. Ankylosing spondylitis. Lancet 2007;369:1379-90.
2. Feldtkeller E, Bruckel J, Khan MA. Scientific contributions of ankylosing spondylitis patient advocacy groups. Curr Opin Rheumatol 2000;12:239-47.
3. Boonen A, van der Linden SM. The burden of ankylosing spondylitis. J Rheumatol Suppl 2006;78:4-11.
4. Sokka T, Abelson B, Pincus T. Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol 2008;26(5 Suppl 51):S35-61.
5. Abuabara K, Azfar RS, Shin DB, et.al. Cause-specific mortality in patients with severe psoriasis: A population-based cohort study in the U.K. Br J Dermatol 2010;163:586-92.
6. Arumugam R, McHugh NJ. Mortality and causes of death in psoriatic arthritis. J Rheumatol Suppl 2012;89:32-5.
7. Selinger CP, Leong RW. Mortality from inflammatory bowel diseases. Inflamm Bowel Dis 2012;18:1566-72.
8. Smith PG, Doll R. Mortality among patients with ankylosing spondylitis after a single treatment course with x rays. Br Med J (Clin Res Ed) 1982;284:449-60.
9. Smith PG, Doll R, Radford EP. Cancer mortality among patients with ankylosing spondylitis not given X-ray therapy. Br J Radiol 1977;50:728-34.
10. Radford EP, Doll R, Smith PG. Mortality among patients with ankylosing spondylitis not given X-ray therapy. N Engl J Med 1977;297:572-6.
11. Lehtinen K. Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis. Ann Rheum Dis 1993;52:174-6.
12. Khan MA, Khan MK, Kushner I. Survival among patients with ankylosing spondylitis: A life-Table analysis. J Rheumatol 1981;8:86-90.
13. Bakland G, Gran JT, Nossent JC. Increased mortality in ankylosing spondylitis is related to disease activity. Ann Rheum Dis 2011;70:1921-5.
14. Brown WM, Doll R. Mortality from cancer and other causes after radiotherapy for ankylosing spondylitis. BMJ 1965;2:1327-32.
15. Darby SC, Doll R, Gill SK, et al. Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis. Br J Cancer 1987;55:179-90.
16. Feltelius N, Ekbom A, Blomqvist P. Cancer incidence among patients with ankylosing spondylitis in Sweden 1965-95: A population based cohort study. Ann Rheum Dis 2003;62:1185-8.
17. Askling J, Klareskog L, Blomqvist P, et al. Risk for malignant lymphoma in ankylosing spondylitis: A nationwide Swedish case-control study. Ann Rheum Dis 2006;65:1184-7.
18. Jordan KP, Joud A, Bergknut C, et al. International comparisons of the consultation prevalence of musculoskeletal conditions using population-based healthcare data from England and Sweden. Ann Rheum Dis 2014;73:212-18.
19. Swedish National Patient Register (Page in Swedish). http://www.socialstyrelsen.se/register/halsodataregister/patientregistret/inenglish.
20. Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health 2011;11:450.
21. Socialstyrelsen. Kodningskvalitet i patientregistretSlutenvard 2008. 2010. (Article in Swedish). http://www.socialstyrelsen.se/publikationer2010/2010-6-27
22. Socialstyrelsen. Kodningskvalitet i patientregistretEtt nytt verktyg för att mäta kvalitet. 2013. (Article in Swedish). http://www.socialstyrelsen.se/publikationer2013/2013-3-10
23. WHO International Classification of Disease codes. http://www.who.int/classifications/icd/en/
24. Statistics Sweden. http://www.scb.se/
25. The Swedish prescribed drug register. (Page in Swedish). http://www.socialstyrelsen. se/register/halsodataregister/lakemedelsregistret
26. Wettermark B, Hammar N, Fored CM, et al. The new Swedish Prescribed Drug Register-opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 2007;16:726-35.
27. Askling J, Fored CM, Geborek P, et al. Swedish registers to examine drug safety and clinical issues in RA. Ann Rheum Dis 2006;65:707-12.
28. Wadström H, Eriksson JK, Neovius M, et al, ARTIS Study Group. How good is the coverage and how accurate are exposure data in the Swedish Biologics Register (ARTIS)? Scand J Rheumatol 2015;44:22-8.
29. The Swedish cause-of-death register. (Page in Swedish). http://www.socialstyrelsen. se/register/dodsorsaksregistret
30. Vander Cruyssen B, Vastesaeger N, Collantes-Estevez E. Hip disease in ankylosing spondylitis. Curr Opin Rheumatol 2013;25:448-54.
31. Kristensen LE, Jakobsen AK, Askling J, et al. Safety of etoricoxib, celecoxib and non-selective NSAIDs in Ankylosing spondylitis and other Spondyloarthritis patients: A Swedish national population based cohort study. Arthritis Care Res (Hoboken) 2015;67:1137-49.
32. Abelson B, Rupel A, Pincus T. Limitations of a biomedical model to explain socioeconomic disparities in mortality of rheumatic and cardiovascular diseases. Clin Exp Rheumatol 2008;26(5 Suppl 51):S25-34.
33. Myllykangas-Luosujarvi R, Aho K, Lehtinen K, et al. Increased incidence of alcohol-related deaths from accidents and violence in subjects with ankylosing spondylitis. Br J Rheumatol 1998;37:688-90.
34. Card TR, Solaymani-Dodaran M, Hubbard R, et al. Is an internal comparison better than using national data when estimating mortality in longitudinal studies? J Epidemiol Community Health 2006;60:819-21.
35. Lindstrom U, Exarchou S, Sigurdardottir V, et al. Validity of ankylosing spondylitis and undifferentiated spondyloarthritis diagnoses in the Swedish National Patient Register. Scand J Rheumatol 2015 [epub ahead of print 23 Mar 2015].
36. Johansson LA, Bjorkenstam C, Westerling R. Unexplained differences between hospital and mortality data indicated mistakes in death certification: An investigation of 1, 094 deaths in Sweden during 1995. J Clin Epidemiol 2009;62:1202-9.
37. Haglund E, Bremander AB, Petersson IF, et al. Prevalence of spondyloarthritis and its subtypes in southern Sweden. Ann Rheum Dis 2011;70:943-8.